INVEGA SUSTENNA® Is Covered for the Majority of Your Patients and May Be Available at Out-of-Pocket Costs Similar to Generics*

Government Coverage Options

Medicare Low-Income Subsidy (LIS)

Full Subsidy-Full Dual Eligible Individuals INVEGA SUSTENNA® patients pay

$0 to $9.85 per dose1†

Through the Medicare Part D Program

Medicaid

Medicaid fee-for-service patients may pay

less than $8 per dose2‡

*For Medicaid, dual-eligible, and Low-Income Subsidy–eligible patients.

See full eligibility requirements for the low-income subsidy for Medicare Prescription Drug Coverage: https://www.cms.gov/Medicare/Eligibility-and-Enrollment/LowIncSubMedicarePresCov/EligibilityforLowIncomeSubsidy

Above 150% of the Federal Poverty Level, patients may pay up to 20% of the amount the Medicaid agency pays. Medicaid Fee-for-Service is a state-specific program. Coverage for INVEGA SUSTENNA®, INVEGA TRINZA®, INVEGA HAFYERA® may depend on the indication as well as other factors. As this information varies by state, it is important to contact the state agency directly or consult its website to obtain product-specific coverage and other information.

Janssen Care Path Logo

Commercial Insurance

§Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give patients their injection. See full eligibility requirements at InvegaSustenna.JanssenCarePathSavings.com.

Online Enrollment of Patients in the Savings Program by You, the Pharmacy, the Patient, or the Caregiver

Providers and pharmacies can use Express Enrollment for the Savings Program at JanssenCarePathPortal.com/express

Comprehensive Provider Portal for the Savings Program and more at JanssenCarePathPortal.com

Patients and caregivers can enroll at MyJanssenCarePath.com/express

Janssen CarePath Is Your One Source for Access, Affordability, and Treatment Support for Your Patients

Janssen CarePath helps verify insurance coverage for your patients, provides reimbursement information, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on prescribed INVEGA SUSTENNA®.

Janssen CarePath can help you find out what affordability assistance may be available for your patients taking INVEGA SUSTENNA®.

Learn More

References: 1. Centers for Medicare & Medicaid Services. Announcement of Calendar Year (CY) 2022 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies: table V-2. January 15, 2021. Accessed September 14, 2022. https://www.cms.gov/files/document/2022-announcement.pdf 2. Medicaid and CHIP Payment and Access Commission. Cost Sharing and Premiums: Benefits. Accessed September 14, 2022. https://www.macpac.gov/subtopic/cost-sharing-and-premiums/